Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

The B.1.617.2 (delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has contributed to a surge in cases in India and has now been detected across the globe, including a notable increase in cases in the United Kingdom. The effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines against this variant has been unclear.

Matéria original

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein

The virological impacts of SARS-CoV-2 D614G mutation

In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein

The virological impacts of SARS-CoV-2 D614G mutation ￼

The virological impacts of SARS-CoV-2 D614G mutation